FDA can't fulfill mission.(POLICY & PRACTICE)(Food and Drug Administration)(Brief article)

From: Internal Medicine News | Date: January 1, 2008| Author: Matthews, Renee | Copyright information

Three members of the Food and Drug Administration's Science Board issued a damning report on the state of the agency, saying that it "suffers from serious scientific deficiencies and is not positioned to meet current or emerging regulatory responsibilities." The authors wrote that the agency has become unable to fulfill its mission because of the increasing demands and a lack of resources, meaning that "American lives a...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

FDA can't fulfill mission.(Policy & Practice)(Food and Drug Administration)(Brief article)
Family Practice News ; Three members of the Food and Drug Administration's Science Board issued a damning report on the state of the agency, saying that it suffers from serious scientific deficiencies and is not positioned to meet current or emerging regulatory responsibilities. The authors wrote that the agency has
The frequency and nature of drug administration error during anaesthesia
Anaesthesia and Intensive Care ; SUMMARY We aimed to establish the frequency and nature of drug administration error in anaesthesia (a significant subset of error in medicine) at two hospitals. Anaesthetists were asked to return a study form anonymously for every anaesthetic, indicating whether or not a drug administration error
BLILEY RELEASES WITNESS LIST FOR FULL COMMITTEE HEARING ON IMPLEMENTATION OF THE FOOD AND DRUG ADMINISTRATION MODERNIZATION
Capitol Hill Press Releases ; 00-00-0000 FOR IMMEDIATE RELEASE CONTACT: Christina Gungoll October 5, 1998 Peter Sheffield (202) 225-5735 !!Attention Daybook Editors!! BLILEY RELEASES WITNESS LIST FOR FULL COMMITTEE HEARING ON IMPLEMENTATION OF THE FOOD AND DRUG ADMINISTRATION MODERNIZATION ACT of 1997 WASHINGTONHouse Commerce
DDMAC cites Prilosec 'misleading' promo.(AstraZeneca PLC)(United States. Food and Drug Administration)(Brief Article)
Medical Marketing & Media ; * Claims in several of AstraZeneca's Prilosec (omeprazole) sales aids that the Food and Drug Administration has alleged were misleading have led to a recently released letter from the Food and Drug Administration's Division of Drug Marketing, Advertising, and Communications. In the letter, the
Analysis: Food and Drug Administration's approval of RU-486, how the drug works and how it will be dispensed
Morning Edition (NPR) ; ... Time: 10:00-11:00 AM BOB EDWARDS, host: This is MORNING EDITION from NPR News. I'm Bob Edwards. After years of debate, the Food and Drug Administration ... powerful political forces lining up in opposition. Joanne Silberner, NPR News, Washington.
FDA report spurs reform.(Pharmaceutical)(Food and Drug Administration)(Brief Article)
R & D ; Released in mid-March, the U,S. Food and Drug Administration (FDA) has issued a report entitled, Challenge and Opportunity on the Critical Path to New Medical Products, outlining its view on the sluggish rate of new pharmaceuticals into the market and possible arenas for new opportunities. Although
Drug administration practices in medical imaging: a survey.
Radiologic Technology ; In 1987 the American College of Radiology approved a resolution that incorporated venipuncture into the scope of practice for radiologic technologists who had received appropriate education. Additionally, in 1991, the American Society of Radiologic Technologists introduced venipuncture as part of
Scientists to Release Survey Demonstrating Dangerous Interference with Science at the Food and Drug Administration
U.S. Newswire ; News Advisory: -- Scientists to Release Survey Demonstrating Dangerous Interference with Science at the Food and Drug Administration ... husband due to side effects of a dangerous anti-depressant -- This event is for media only. For additional information on the news conference, please call Eric Young at (202) ...
FDA speeds pharmaceutical product reviews. (Pharmaceutical).(US Food and Drug Administration)(Brief Article)
R & D ; The US Food and Drug Administration (FDA) has announced a consolidation of responsibilities for reviewing new pharmaceutical products. Drug and biological product reviews have been conducted in part by the FDA's Center for Biologics Evaluation and Research (CBER) and also by its Center for Drug
FDA Releases Draft I.T. Plan.(Food and Drug Administration)(Information Technology )(Brief article)
Health Data Management ; The Food and Drug Administration has released for public comment its Prescription Drug User Fee Act IV Information Technology Plan. The agencys intent is to provide regulated industry and other stakeholders with information on its vision for improving the automation of business processes and